The U.S. Department of Justice said Wednesday that Irish drugmaker Shire will pay $56.5 million to settle allegations it broke the law in promoting five different drugs, including its attention deficit disorder drugs Adderall XR and Vyvanse. According to a whistleblower lawsuit, Shire said ADHD patients who took Adderall XR would be "indistinguishable" from people who don't have the condition.